首页> 外文OA文献 >A novel type of familial hypercholesterolemia: Double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene
【2h】

A novel type of familial hypercholesterolemia: Double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene

机译:a novel type of familial hypercholesterolemia: Double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Autosomal recessive hypercholesterolemia (ARH) is an extremely rare inherited hypercholesterolemia, the cause of which is mutations in low-density lipoprotein (LDL) receptor adaptor protein 1 (LDLRAP1) gene. Methods: A total of 146 heterozygous familial hypercholesterolemic (FH) patients with a mutation in LDLR gene were screened for genes encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) and LDLRAP1. Results: Among the 146 subjects, we identified a 79-year-old Japanese female with double mutations in LDLR gene (c.2431A > T) and LDLRAP1 gene (c.606dup). Two other relatives with double mutations in those genes in her family were also identified. Although the proband exhibited massive Achilles tendon xanthoma and coronary and aortic valvular disease, serum LDL-C level of subjects with double mutations was similar with that of subjects with single LDLR mutation (284.0 ± 43.5 versus 265.1 ± 57.4 mg/dl). Conclusion: Additional mutation in LDLRAP1 may account for severer phenotype in terms of xanthoma and atherosclerotic cardiovascular disease in FH patients. © 2011 Elsevier Ireland Ltd. All rights reserved.
机译:背景:常染色体隐性遗传性高胆固醇血症(ARH)是一种极为罕见的遗传性高胆固醇血症,其原因是低密度脂蛋白(LDL)受体衔接蛋白1(LDLRAP1)基因的突变。方法:筛选146例LDLR基因突变的杂合子家族性高胆固醇血症(FH)患者,寻找其编码前蛋白转化酶枯草杆菌蛋白酶/ kexin 9型(PCSK9)和LDLRAP1的基因。结果:在146名受试者中,我们鉴定出一名79岁的日本女性,其LDLR基因(c.2431A> T)和LDLRAP1基因(c.606dup)有双重突变。还确定了她的家庭中其他两个在这些基因中具有双重突变的亲戚。尽管先证者表现出大量跟腱黄瘤以及冠状动脉和主动脉瓣膜疾病,但具有双重突变的受试者的血清LDL-C水平与具有单一LDLR突变的受试者的血清LDL-C水平相似(284.0±43.5对265.1±57.4 mg / dl)。结论:LDLRAP1的额外突变可能导致FH患者的黄瘤和动脉粥样硬化性心血管疾病的严重表型。 ©2011爱思唯尔爱尔兰有限公司。保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号